
Kyle Zhai
Examiner (ID: 13723, Phone: (571)270-3740 , Office: P/2612 )
| Most Active Art Unit | 2612 |
| Art Unit(s) | 2612, 2679, 2628, 2677, 2611 |
| Total Applications | 523 |
| Issued Applications | 359 |
| Pending Applications | 53 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17525748
[patent_doc_number] => 11298414
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Cellular adjuvants for viral infection
[patent_app_type] => utility
[patent_app_number] => 16/536962
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 12
[patent_no_of_words] => 8176
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536962 | Cellular adjuvants for viral infection | Aug 8, 2019 | Issued |
Array
(
[id] => 16656080
[patent_doc_number] => 20210052716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => A novel K-serotype Vibrio parahaemolyticus and application
[patent_app_type] => utility
[patent_app_number] => 16/771693
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771693 | Method for preparing a K serum with a vibrio parahaemolyticus as an antigen | Jul 29, 2019 | Issued |
Array
(
[id] => 15432423
[patent_doc_number] => 20200030394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING THE EYE
[patent_app_type] => utility
[patent_app_number] => 16/519149
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12434
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519149 | Compositions and methods for treating the eye | Jul 22, 2019 | Issued |
Array
(
[id] => 15408623
[patent_doc_number] => 20200024633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => ANTIMICROBIAL SUSCEPTIBILITY TESTING AND MICROBIAL IDENTIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/516184
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16516184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/516184 | Antimicrobial susceptibility testing and microbial identification | Jul 17, 2019 | Issued |
Array
(
[id] => 16695513
[patent_doc_number] => 10946082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Immunomodulatory compositions and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/511847
[patent_app_country] => US
[patent_app_date] => 2019-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 30
[patent_no_of_words] => 51676
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/511847 | Immunomodulatory compositions and methods of use thereof | Jul 14, 2019 | Issued |
Array
(
[id] => 15931045
[patent_doc_number] => 20200157156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => GRATELOUPIA CHIANGII-DERIVED LECTIN AND LECTIN GENE CODING FOR THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/509513
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16509513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/509513 | GRATELOUPIA CHIANGII-DERIVED LECTIN AND LECTIN GENE CODING FOR THE SAME | Jul 11, 2019 | Abandoned |
Array
(
[id] => 16549750
[patent_doc_number] => 10882899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Anti
[patent_app_type] => utility
[patent_app_number] => 16/503211
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 13
[patent_no_of_words] => 13231
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503211
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/503211 | Anti | Jul 2, 2019 | Issued |
Array
(
[id] => 16885766
[patent_doc_number] => 20210171961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM
[patent_app_type] => utility
[patent_app_number] => 17/255270
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255270 | SELECTION AND GENETIC MODIFICATION OF PLANT ASSOCIATED METHYLOBACTERIUM | Jul 2, 2019 | Pending |
Array
(
[id] => 14833379
[patent_doc_number] => 20190275090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/423487
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423487
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423487 | Treatment of | May 27, 2019 | Issued |
Array
(
[id] => 16651222
[patent_doc_number] => 10928394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Rapid test for lyme bacteria
[patent_app_type] => utility
[patent_app_number] => 16/422802
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5579
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422802
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/422802 | Rapid test for lyme bacteria | May 23, 2019 | Issued |
Array
(
[id] => 16792998
[patent_doc_number] => 20210122815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => ANTI-INTERLEUKIN-17A ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/055252
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055252
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055252 | ANTI-INTERLEUKIN-17A ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | May 23, 2019 | Pending |
Array
(
[id] => 16468494
[patent_doc_number] => 20200370031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => MULTILAYER NANO-CELL CONTAINING BIOMOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/419508
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419508 | Multilayer nano-cell containing biomolecules | May 21, 2019 | Issued |
Array
(
[id] => 15117205
[patent_doc_number] => 20190345235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => Type III Secretion System Targeting Molecules
[patent_app_type] => utility
[patent_app_number] => 16/419677
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419677 | Type III secretion system targeting molecules | May 21, 2019 | Issued |
Array
(
[id] => 18591346
[patent_doc_number] => 11740237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Biomarkers for detecting microbial infection
[patent_app_type] => utility
[patent_app_number] => 17/052731
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16733
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052731 | Biomarkers for detecting microbial infection | May 2, 2019 | Issued |
Array
(
[id] => 15020897
[patent_doc_number] => 20190321453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/394666
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394666 | UNIVERSAL PLATFORM FOR TARGETING THERAPIES TO TREAT NEUROLOGICAL DISEASES | Apr 24, 2019 | Abandoned |
Array
(
[id] => 16882891
[patent_doc_number] => 20210169086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => INHIBITION OF FUNGAL GROWTH BY MANGANESE DEPLETION
[patent_app_type] => utility
[patent_app_number] => 17/047900
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13309
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047900 | Inhibition of fungal growth by manganese depletion | Apr 16, 2019 | Issued |
Array
(
[id] => 18045032
[patent_doc_number] => 11518973
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Device and method for automated antibiotic susceptibility testing of gram-negative bacteria
[patent_app_type] => utility
[patent_app_number] => 16/638419
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 3667
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 214
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638419 | Device and method for automated antibiotic susceptibility testing of gram-negative bacteria | Mar 18, 2019 | Issued |
Array
(
[id] => 14833467
[patent_doc_number] => 20190275134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => VACCINES AGAINST URINARY TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/299907
[patent_app_country] => US
[patent_app_date] => 2019-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299907 | VACCINES AGAINST URINARY TRACT INFECTIONS | Mar 11, 2019 | Abandoned |
Array
(
[id] => 14531641
[patent_doc_number] => 20190201441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS
[patent_app_type] => utility
[patent_app_number] => 16/296677
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296677
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/296677 | AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS | Mar 7, 2019 | Abandoned |
Array
(
[id] => 16786223
[patent_doc_number] => 10988638
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Process to reduce endotoxin in gelatin
[patent_app_type] => utility
[patent_app_number] => 16/295223
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 10304
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/295223 | Process to reduce endotoxin in gelatin | Mar 6, 2019 | Issued |